• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂从溶胶-凝胶法制备的有机改性二氧化硅干凝胶中的体外释放。

In vitro release of cisplatin from sol-gel processed organically modified silica xerogels.

作者信息

Czarnobaj Katarzyna, Lukasiak Jerzy

机构信息

Department of Physical Chemistry with Laboratory of Instrumental Analysis, Medical University of Gdansk, al. Gen. J. Hallera 107, Gdansk 80-416, Poland.

出版信息

J Mater Sci Mater Med. 2007 Oct;18(10):2041-4. doi: 10.1007/s10856-007-3139-x. Epub 2007 Jun 9.

DOI:10.1007/s10856-007-3139-x
PMID:17558477
Abstract

SiO2, SiO2/PEG and SiO2/PDMS xerogels were examined as polymeric carriers for the controlled release of cisplatin--an antineoplasmic medicine. Drug/carrier systems were prepared by the sol-gel method. The effect of organic substitution of the silica xerogel matrix and drying conditions on the release of cisplatin was evaluated. Based on the presented results of the study it may be stated that sol-gel method is useful for entrapping a cisplatin in the pores of organically modified silica gels and for releasing cisplatin mainly in the way of diffusion from the pores of the lattice under the in vitro conditions. The use of organic impurities in silica gel increased the release of cisplatin from xerogel (from 62% to 97% within 7 days), and thermal treatment of all xerogels with cisplatin at the temperature of 80 degrees C resulted in the acceleration of the drug release (2 days) and increase of the released drug (89-98%).

摘要

二氧化硅(SiO₂)、二氧化硅/聚乙二醇(SiO₂/PEG)和二氧化硅/聚二甲基硅氧烷(SiO₂/PDMS)干凝胶作为顺铂(一种抗肿瘤药物)控释的聚合物载体进行了研究。药物/载体系统通过溶胶-凝胶法制备。评估了二氧化硅干凝胶基质的有机取代和干燥条件对顺铂释放的影响。根据本研究给出的结果,可以说溶胶-凝胶法可用于将顺铂包封在有机改性硅胶的孔隙中,并且在体外条件下,顺铂主要以从晶格孔隙扩散的方式释放。硅胶中使用有机杂质增加了顺铂从干凝胶中的释放(7天内从62%增加到97%),并且在80℃温度下对所有含顺铂的干凝胶进行热处理导致药物释放加速(2天)和释放药物增加(89%-98%)。

相似文献

1
In vitro release of cisplatin from sol-gel processed organically modified silica xerogels.顺铂从溶胶-凝胶法制备的有机改性二氧化硅干凝胶中的体外释放。
J Mater Sci Mater Med. 2007 Oct;18(10):2041-4. doi: 10.1007/s10856-007-3139-x. Epub 2007 Jun 9.
2
The effect of PEG concentration on the release rate of cisplatin from PEG-modified silica xerogels.聚乙二醇(PEG)浓度对顺铂从PEG修饰的二氧化硅干凝胶中释放速率的影响。
Drug Deliv. 2006 Sep-Oct;13(5):339-44. doi: 10.1080/10717540500394752.
3
Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine.用于双氯芬酸二乙胺控释的溶胶-凝胶法制备的多孔二氧化硅载体
J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):114-20. doi: 10.1002/jbm.b.31076.
4
In vitro release of cisplatin from sol-gel processed porous silica xerogels.顺铂从溶胶-凝胶法制备的多孔二氧化硅干凝胶中的体外释放。
Drug Deliv. 2004 Nov-Dec;11(6):341-4. doi: 10.1080/10717540490507451.
5
Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.通过一步溶胶-凝胶法将药物包封于二氧化硅微球及其体外释放行为
J Biomed Mater Res B Appl Biomater. 2006 Apr;77(1):149-55. doi: 10.1002/jbm.b.30416.
6
The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.碳酸钠、氟化钠和氨水溶液对溶胶-凝胶法制备的载药硅干凝胶的稳定性和释放行为的影响。
Acta Biomater. 2010 Jun;6(6):2246-53. doi: 10.1016/j.actbio.2009.12.021. Epub 2009 Dec 24.
7
In-vitro controlled release of doxorubicin from silica xerogels.阿霉素从硅胶干凝胶中的体外控释
J Pharm Pharmacol. 2007 Oct;59(10):1365-73. doi: 10.1211/jpp.59.10.0006.
8
Preparation and characterization of silica xerogels as carriers for drugs.作为药物载体的二氧化硅干凝胶的制备与表征
Drug Deliv. 2008 Nov;15(8):485-92. doi: 10.1080/10717540802321495.
9
Silica xerogel carrier material for controlled release of toremifene citrate.用于柠檬酸托瑞米芬控释的二氧化硅干凝胶载体材料。
Int J Pharm. 2000 Feb 15;195(1-2):219-27. doi: 10.1016/s0378-5173(99)00403-2.
10
Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.载阿霉素二氧化硅/聚二甲基硅氧烷干凝胶的理化性质与药物体外释放的相关性
Acta Biomater. 2009 Jan;5(1):193-207. doi: 10.1016/j.actbio.2008.07.027. Epub 2008 Aug 6.

引用本文的文献

1
Antitumoral materials with regenerative function obtained using a layer-by-layer technique.采用逐层技术获得的具有再生功能的抗肿瘤材料。
Drug Des Devel Ther. 2015 Mar 2;9:1269-79. doi: 10.2147/DDDT.S62805. eCollection 2015.
2
The bio-functional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro.介孔硅气凝胶中钙的生物功能作用对体外成骨细胞反应的影响。
J Mater Sci Mater Med. 2010 Jul;21(7):2175-85. doi: 10.1007/s10856-010-4083-8. Epub 2010 Apr 22.

本文引用的文献

1
Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.溶胶-凝胶法合成多功能、具有分级孔隙结构的二氧化硅/磷灰石复合材料。
Biomaterials. 2005 Dec;26(34):6827-35. doi: 10.1016/j.biomaterials.2005.05.002.
2
Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles.顺铂从聚(丙烯酸-co-甲基丙烯酸甲酯)微粒中的释放
J Control Release. 2005 Aug 18;106(1-2):198-208. doi: 10.1016/j.jconrel.2005.05.005.
3
Development of a simple method for the preparation of a silica gel based controlled delivery system with a high drug content.
开发一种制备具有高药物含量的硅胶基控释系统的简单方法。
Eur J Pharm Sci. 2005 Sep;26(1):87-96. doi: 10.1016/j.ejps.2005.05.002.
4
Sol-gel processing of drug delivery materials and release kinetics.药物递送材料的溶胶-凝胶加工及释放动力学
J Mater Sci Mater Med. 2005 Mar;16(3):261-5. doi: 10.1007/s10856-005-6688-x.
5
In vitro release of cisplatin from sol-gel processed porous silica xerogels.顺铂从溶胶-凝胶法制备的多孔二氧化硅干凝胶中的体外释放。
Drug Deliv. 2004 Nov-Dec;11(6):341-4. doi: 10.1080/10717540490507451.
6
Apatite-forming ability and mechanical properties of PTMO-modified CaO-SiO2-TiO2 hybrids derived from sol-gel processing.溶胶-凝胶法制备的PTMO改性CaO-SiO₂-TiO₂杂化材料的磷灰石形成能力及力学性能
Biomaterials. 2004 Jan;25(1):1-7. doi: 10.1016/s0142-9612(03)00463-0.
7
[Evaluation of the usefulness of spectrophotometric method based on the reaction of formation of silic-molybdenum blue for determination of silica in hydrogenated fat].[基于硅钼蓝形成反应的分光光度法测定氢化脂肪中二氧化硅的实用性评估]
Rocz Panstw Zakl Hig. 2002;53(3):259-65.
8
In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials.用作控释材料的二氧化硅干凝胶的体外生物活性和降解行为。
Biomaterials. 2002 Aug;23(15):3113-22. doi: 10.1016/s0142-9612(02)00051-0.
9
Silica xerogel carrier material for controlled release of toremifene citrate.用于柠檬酸托瑞米芬控释的二氧化硅干凝胶载体材料。
Int J Pharm. 2000 Feb 15;195(1-2):219-27. doi: 10.1016/s0378-5173(99)00403-2.
10
Silica xerogel as an implantable carrier for controlled drug delivery--evaluation of drug distribution and tissue effects after implantation.硅胶干凝胶作为用于药物控释的可植入载体——植入后药物分布及组织效应评估
Biomaterials. 2000 Jan;21(2):193-8. doi: 10.1016/s0142-9612(99)00148-9.